ilmscore | 🚨 HIMS STOCK ANALYSIS: BUY OR SELL BEFORE EARNINGS!?!

🚨 HIMS STOCK ANALYSIS: BUY OR SELL BEFORE EARNINGS!?!

Published: 2025-02-23
Status: Analyzed

Predictions from this Video

Total: 4
Correct: 0
Incorrect: 0
Pending: 4
Prediction
Topic
Status
Demand for Hims' Ozempic alternative will naturally decrease once the shortage of the original drug ends.
"but once the shortage is no longer and therefore people can go back to not the alternative of hyms it's not that people will always will but again just demand naturally will not be as high as possibly of what it was overall with this OIC uh alternative for hims"
HS
Pending
Hims & Hers (HS) is predicted to exceed market expectations for its Q4 2024 earnings.
"I do believe that they might even fully exceed expectation for their earnings"
HS
Pending
Hims & Hers (HS) stock price is predicted to reach at least $73 per share in a best-case scenario.
"the best case scenario is this thing breaks out and goes back up to at least $73 per share"
HS
Pending
Hims & Hers (HS) stock price has the potential to drop 50-52% to $23 per share.
"it comes at the risk of this potentially losing 50% right 52% back down to $23 per share"
HS
Pending